ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2020

Oct 26, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2020-10-08

Reporting Person: De Backer Marianne (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-08	Common Stock	P	500	$50.93	Acquired	17000	Direct
2020-10-08	Common Stock	P	500	$50.00	Acquired	17500	Direct